Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sigyn Therapeutics Inc
(OP:
SIGY
)
0.0840
UNCHANGED
Streaming Delayed Price
Updated: 3:57 PM EDT, Mar 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.0840
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0840
Today's Range
0.0840 - 0.0840
52wk Range
0.0220 - 5.000
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Sigyn Therapeutics Issues Shareholder Update Regarding Potential Merger and Asset Sale Initiatives
March 13, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Sigyn Therapeutics Issues Shareholder Update Regarding Potential Merger and Asset Sale Initiatives
March 13, 2026
SAN DIEGO, CA - March 13, 2026 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a developer of dialysis-like therapies to address cardiovascular disease and cancer,...
Via
TheNewswire.com
Performance
YTD
-91.6%
-91.6%
1 Month
-44.0%
-44.0%
3 Month
-95.1%
-95.1%
6 Month
-97.6%
-97.6%
1 Year
-98.0%
-98.0%
More News
Read More
Sigyn Therapeutics Issues Shareholder Update Highlighting the Advancement of CardioDialysis(TM) and New Corporate Initiatives
January 15, 2026
Via
NewMediaWire
Sigyn Therapeutics Issues Shareholder Update Highlighting the Advancement of CardioDialysis(TM) and New Corporate Initiatives
January 15, 2026
Via
TheNewswire.com
Sigyn Therapeutics Announces Cardiovascular Disease Study
September 03, 2025
Via
TheNewswire.com
Topics
Death
The Emergence of Blood Purification Devices to Treat Cardiovascular Disease
January 06, 2026
Via
NewMediaWire
The Emergence of Blood Purification Devices to Treat Cardiovascular Disease
January 06, 2026
Via
TheNewswire.com
Sigyn CEO Note: First-In-Industry Attributes of CardioDialysisTM to Treat Cardiovascular Disease
December 11, 2025
Via
NewMediaWire
Sigyn CEO Note: First-In-Industry Attributes of CardioDialysisTM to Treat Cardiovascular Disease
December 11, 2025
Via
TheNewswire.com
Sigyn CEO Note: Nature Publication Reinforces Rationale for CardioDialysisTM to Address Cardiovascular Disease in Dialysis Patients
December 03, 2025
Via
NewMediaWire
Sigyn CEO Note: Nature Publication Reinforces Rationale for CardioDialysisTM to Address Cardiovascular Disease in Dialysis Patients
December 03, 2025
Via
TheNewswire.com
Sigyn CardioDialysis(TM) Featured on the Big Biz Show
November 18, 2025
Via
NewMediaWire
Topics
Death
Sigyn CardioDialysis(TM) Featured on the Big Biz Show
November 18, 2025
Via
TheNewswire.com
Topics
Death
Sigyn Therapeutics Reports Third Quarter Financial Results and Subsequent Introduction of CardioDialysis(TM)
November 14, 2025
Via
TheNewswire.com
Topics
Intellectual Property
Sigyn Therapeutics Reports Third Quarter Financial Results and Subsequent Introduction of CardioDialysis(TM)
November 14, 2025
Via
NewMediaWire
Topics
Intellectual Property
Sigyn Therapeutics Releases Shareholder Letter to Introduce CardioDialysis(TM)
November 06, 2025
Via
NewMediaWire
Topics
Intellectual Property
Sigyn Therapeutics Releases Shareholder Letter to Introduce CardioDialysis(TM)
November 06, 2025
Via
TheNewswire.com
Topics
Intellectual Property
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
September 18, 2025
From
Virtual Investor Conferences
Via
GlobeNewswire
Sigyn Therapeutics to Present at the Life Sciences Virtual Investor Forum on September 18th
September 16, 2025
From
Virtual Investor Conferences
Via
GlobeNewswire
Life Science Virtual Investor Forum Agenda Announced for September 18th
September 16, 2025
From
Virtual Investor Conferences
Via
GlobeNewswire
Sigyn Therapeutics Appoints Dr. Christoph Zaba to Its Scientific Advisory Board
September 11, 2025
Via
NewMediaWire
Sigyn Therapeutics Appoints Dr. Christoph Zaba to Its Scientific Advisory Board
September 11, 2025
Via
TheNewswire.com
Sigyn Therapeutics Announces Cardiovascular Disease Study
September 03, 2025
Via
NewMediaWire
Topics
Death
RETRANSMISSION: Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.
July 01, 2025
Via
ACCESS Newswire
Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.
July 01, 2025
Via
ACCESS Newswire
Frequently Asked Questions
Is Sigyn Therapeutics Inc publicly traded?
Yes, Sigyn Therapeutics Inc is publicly traded.
What exchange does Sigyn Therapeutics Inc trade on?
Sigyn Therapeutics Inc trades on the OTC Traded
What is the ticker symbol for Sigyn Therapeutics Inc?
The ticker symbol for Sigyn Therapeutics Inc is SIGY on the OTC Traded
What is the current price of Sigyn Therapeutics Inc?
The current price of Sigyn Therapeutics Inc is 0.0840
When was Sigyn Therapeutics Inc last traded?
The last trade of Sigyn Therapeutics Inc was at 03/13/26 03:57 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
